DE60214676D1 - Hochaffine antagonisten der elr-cxc chemokine - Google Patents
Hochaffine antagonisten der elr-cxc chemokineInfo
- Publication number
- DE60214676D1 DE60214676D1 DE60214676T DE60214676T DE60214676D1 DE 60214676 D1 DE60214676 D1 DE 60214676D1 DE 60214676 T DE60214676 T DE 60214676T DE 60214676 T DE60214676 T DE 60214676T DE 60214676 D1 DE60214676 D1 DE 60214676D1
- Authority
- DE
- Germany
- Prior art keywords
- antagonists
- elr
- cxc
- chemokins
- high affine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5421—IL-8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27318101P | 2001-03-01 | 2001-03-01 | |
US273181P | 2001-03-01 | ||
PCT/CA2002/000271 WO2002070565A2 (en) | 2001-03-01 | 2002-03-01 | High-affinity antagonists of elr-cxc chemokines |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60214676D1 true DE60214676D1 (de) | 2006-10-26 |
DE60214676T2 DE60214676T2 (de) | 2007-09-20 |
Family
ID=23042842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60214676T Expired - Lifetime DE60214676T2 (de) | 2001-03-01 | 2002-03-01 | Hochaffine antagonisten der elr-cxc chemokine |
Country Status (11)
Country | Link |
---|---|
US (3) | US7201895B2 (de) |
EP (1) | EP1363944B1 (de) |
JP (1) | JP2004534521A (de) |
AT (1) | ATE339447T1 (de) |
AU (1) | AU2002237136B2 (de) |
CA (1) | CA2439452C (de) |
DE (1) | DE60214676T2 (de) |
DK (1) | DK1363944T3 (de) |
ES (1) | ES2274957T3 (de) |
HK (1) | HK1062689A1 (de) |
WO (1) | WO2002070565A2 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002237136B2 (en) | 2001-03-01 | 2007-11-01 | University Of Saskatchewan | High-affinity antagonists of ELR-CXC chemokines |
MX2008014656A (es) * | 2006-05-16 | 2009-01-30 | Univ Saskatchewan | Antagonistas de las quimiocinas cxc-elr de alta afinidad. |
US8252741B2 (en) | 2008-02-12 | 2012-08-28 | Gordon John R | Uses of modified ELR-CXC chemokine G31P |
US8299019B2 (en) * | 2008-02-12 | 2012-10-30 | Gordon John R | Uses of modified ELR-CXC chemokine G31P to treat cancer |
KR101247641B1 (ko) | 2010-10-22 | 2013-03-29 | 성균관대학교산학협력단 | Cxcr2에 결합하는 펩타이드 리간드를 포함하는 감염성 및 염증성 질환 치료용 조성물 |
AU2012222832B2 (en) | 2011-03-03 | 2017-03-30 | Denovamed Inc. | Antimicrobial/adjuvant compounds and methods |
US10301378B2 (en) | 2013-06-18 | 2019-05-28 | New York University | Cellular factors involved in the cytotoxicity of Staphylococcus aureus leukocidins: novel therapeutic targets |
US10075024B2 (en) | 2015-05-22 | 2018-09-11 | La-Z-Boy Incorporated | Apparatus and method for wireless power transfer in furniture |
EP3551034A1 (de) | 2016-12-07 | 2019-10-16 | Progenity, Inc. | Verfahren, vorrichtungen und systeme zur detektion des magen-darm-trakts |
CA3045310A1 (en) | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
CN109022599A (zh) * | 2018-10-08 | 2018-12-18 | 河南科技学院 | 检测奶牛CCL28基因单核苷酸多态性的试剂盒及RFLP方法及相关SNPs |
US20220249814A1 (en) | 2018-11-19 | 2022-08-11 | Progenity, Inc. | Methods and devices for treating a disease with biotherapeutics |
US11707610B2 (en) | 2019-12-13 | 2023-07-25 | Biora Therapeutics, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3078892A (en) * | 1991-12-04 | 1993-06-28 | Biomedical Research Centre Limited, The | Human interleukin-8 analogs |
AU6283996A (en) * | 1995-06-20 | 1997-01-22 | Chiron Corporation | Polypeptides with interleukin-8 receptor binding |
AU2002237136B2 (en) | 2001-03-01 | 2007-11-01 | University Of Saskatchewan | High-affinity antagonists of ELR-CXC chemokines |
-
2002
- 2002-03-01 AU AU2002237136A patent/AU2002237136B2/en not_active Ceased
- 2002-03-01 CA CA2439452A patent/CA2439452C/en not_active Expired - Fee Related
- 2002-03-01 EP EP02703428A patent/EP1363944B1/de not_active Expired - Lifetime
- 2002-03-01 DE DE60214676T patent/DE60214676T2/de not_active Expired - Lifetime
- 2002-03-01 JP JP2002570602A patent/JP2004534521A/ja active Pending
- 2002-03-01 ES ES02703428T patent/ES2274957T3/es not_active Expired - Lifetime
- 2002-03-01 AT AT02703428T patent/ATE339447T1/de not_active IP Right Cessation
- 2002-03-01 WO PCT/CA2002/000271 patent/WO2002070565A2/en active IP Right Grant
- 2002-03-01 DK DK02703428T patent/DK1363944T3/da active
- 2002-03-01 US US10/087,273 patent/US7201895B2/en not_active Expired - Lifetime
-
2004
- 2004-05-27 HK HK04103755A patent/HK1062689A1/xx not_active IP Right Cessation
-
2006
- 2006-05-16 US US11/434,155 patent/US20070021593A1/en not_active Abandoned
-
2008
- 2008-07-14 US US12/172,333 patent/US7741434B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2274957T3 (es) | 2007-06-01 |
US20030077705A1 (en) | 2003-04-24 |
WO2002070565A2 (en) | 2002-09-12 |
US20090118469A1 (en) | 2009-05-07 |
WO2002070565A3 (en) | 2002-12-19 |
EP1363944B1 (de) | 2006-09-13 |
JP2004534521A (ja) | 2004-11-18 |
CA2439452A1 (en) | 2002-09-12 |
US7741434B2 (en) | 2010-06-22 |
WO2002070565A9 (en) | 2002-10-31 |
AU2002237136B2 (en) | 2007-11-01 |
US20070021593A1 (en) | 2007-01-25 |
US7201895B2 (en) | 2007-04-10 |
EP1363944A2 (de) | 2003-11-26 |
ATE339447T1 (de) | 2006-10-15 |
DK1363944T3 (da) | 2007-01-08 |
HK1062689A1 (en) | 2004-11-19 |
DE60214676T2 (de) | 2007-09-20 |
CA2439452C (en) | 2012-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200301073A1 (ru) | N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора | |
SG158141A1 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
DE60214676D1 (de) | Hochaffine antagonisten der elr-cxc chemokine | |
ATE541857T1 (de) | Optimierte fc-varianten und herstellungsverfahren dafür | |
DK1543002T3 (da) | Fremstilling af 1H-imidazo (4,5-c) quinolin-4-aminer via 1H-imidazo (4,5-c) quinolin-4-phtalimid mellemprodukter | |
TNSN07196A1 (en) | Potentiators of glutamate receptors | |
SG149693A1 (en) | Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | |
TW200631594A (en) | Toll like receptor 3 antagonists, methods and uses | |
SG157952A1 (en) | Small molecule antagonists of bcl-2 family proteins | |
SG167664A1 (en) | 2,4-pyrimidinediamine compounds and their uses | |
MXPA04003333A (es) | Remodelado y glicoconjugacion de peptidos. | |
DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
DK1292304T3 (da) | Zolpidem Hemitartrat | |
ATE312096T1 (de) | Neue verbindungen | |
WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
EA200601743A1 (ru) | Выделенный полипептид реналазы и его применение | |
WO2005042717A3 (en) | Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods | |
SG158098A1 (en) | Toll like receptor 3 antagonists, methods and uses | |
BRPI0507173A (pt) | método para produzir polìmeros de polifenileno substituìdo | |
DE60218183D1 (de) | Methoden für die konstruktion und screening von chemokine varianten | |
SE0303418D0 (sv) | New use 1 | |
CY1117092T1 (el) | Μοτιβα της οικογενειας παγκρεατικων πολυπεπτιδιων, πολυπεπτιδια και μεθοδοι που τα περιλαμβανουν | |
SE0303419D0 (sv) | New use 11 | |
MXPA04001166A (es) | Usos de citocina de mamifero; reactivos relacionados. | |
SE0303489D0 (sv) | New use VII |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBH, 805 |